-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
-
Summary
-
Aardvark Therapeutics, Inc. quarterly Liabilities history and change rate from Q4 2024 to Q3 2025.
- Aardvark Therapeutics, Inc. Liabilities for the quarter ending September 30, 2025 was $10.9M.